Table 5.
Ovarian cancer in pregnancy in the literature and patient outcomes.
| Study | Year of Publication | Country | Years | Number of Cases of Ovarian Malignancy | Type of Malignancy (Number) | Stage of Malignancy (Number of Cases) | Relapses (Number) | Deaths (Number) |
|---|---|---|---|---|---|---|---|---|
| Cottreau et al. [82] | 2019 | US, 5 states | 2001–2013 | 44 | ovarian cancer | no data | no data | incomplete data |
| de Haan et al. [73] | 2018 | Europe, 16 countries | 1996–2016 | 88 | ovarian cancer | stage I—66 cases stage II—4 cases stage III—7 cases stage IV—2 cases unknown—9 cases |
no data | 0 during pregnancy |
| Parazzini et al. [80] | 2017 | Italy, Lombardia | 2001–2012 | 45 | ovarian cancer | no data | no data | incomplete data |
| Shim et al. [16] | 2016 | South Korea | 1995–2013 | 5 | ovarian cancer: EOC (4), dysgerminoma (1) | stage I—5 cases | 0 | 1 |
| Zhao et al. [24] | 2016 | China | 1985–2003 | 22 | ovarian cancer: germ cell tumor (9), EOC (5), sex cord stromal tumor (2) + LMP tumor (5) | stage I—16 cases, stage II—1 case, stage III—3 cases, stage IV—2 cases | 4 | 4 |
| Andersson et al. [83] | 2015 | Sweden | 1963–2007 | 175 | ovarian cancer | no data | no data | incomplete data |
| Nazer et al. [84] | 2015 | US | 2003–2011 | 180 | ovarian cancer (93) + low malignant potential tumor (87) | incomplete data | no data | no data |
| Morikawa et al. [81] | 2014 | Japan | 1985–2010 | 41 | ovarian cancer: borderline tumor (25), EOC (8), germ cell tumor (7), sex cord stromal tumor (1) | stage I—38 cases, stage II—1 case, stage III—1 case, stage IV—1 case | incomplete data | incomplete data |
| Eibye et al. [85] | 2013 | Denmark | 1977–2006 | 74 | ovarian cancer | incomplete data | no data | no data |
| Lee et al. [79] | 2012 | Australia, New South Wales | 1994–2008 | 47 | ovarian cancer | incomplete data | no data | incomplete data |
| Fauvet et al. [22] | 2011 | France, 6 centers | 1997–2009 | 40 | ovarian cancer: borderline tumor (40) | stage I—35 cases, stage II—2 cases, stage III—2 cases, staging not available—1 case | 3 | 0 |
| Kwon et al. [86] | 2010 | South Korea | 1996–2006 | 27 | ovarian cancer: borderline tumor (15), EOC (7), germ cell tumor (5) | no data | 1 | 0 |
| Van Calsteren et al. [1] | 2010 | Europe: Belgium, The Netherlands, Czech Republic | 1998–2008 | 4 | ovarian cancer | no data | incomplete data | no data |
| Stensheim et al. [87] | 2009 | Norway | 1967–2002 | 53 | ovarian cancer | incomplete data | no data | 11 |
| Behtash et al. [27] | 2008 | Iran | 1991–2002 | 23 | ovarian cancer: EOC (5), germ cell tumor (11), sex cord stromal tumor (3)+ LMP (5) | stage I—17 cases, stage II—1 case, stage III—3 cases, stage IV—1 case | 5 | 5 |
| Leiserowitz et al. [11] | 2006 | US, California | 1991–1999 | 202 | ovarian cancer: EOC (52), germ cell tumor (34), sex cord stromal tumor (1) + low malignant potential tumor (115) | incomplete data | no data | no data |
| Smith et al. [3] | 2003 | US, California | 1991–1999 | 253 | ovarian cancer | no data | no data | incomplete data |
| Matsuyama et al. [41] |
1989 | Japan | 1978–1986 | 6 | ovarian cancer: EOC (4), immature teratoma (1), metastatic cancer of colon origin (1) | stage I—4 cases, stage III 1 case, stage IV—1 case | 1 | 1 |
| Haas [68] | 1984 | GDR | 1970–1979 | 20 | ovarian cancer | incomplete data | no data | no data |
EOC- epithelial ovarian cancer; GDR- German Democratic Republic; US- United States.